In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Genta licenses bone therapeutic from Relgen
IDM Obtains cancer vaccine patent
Procyon gains additional patent protection for cancer screening test
MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe
Genta Acquires C-Myb Antisense Drug Clinical-Stage Compound Targets a Key Cancer Control Gene
Genta and Aventis terminate Genasense® agreements
Genta Announces Termination of Genasense® Agreements by Aventis
Genta and Aventis enter worldwide collaboration
Genta amends collaboration with Aventis
CuraGen to present discovery and development approach for oncology therapeutics